Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Impaired work ability, Magnetic resonance imaging, Nausea
Clinical narrative: headache; head pressure; nausea; blurred vision; nystagmus; tinnitus in left ear; Vertigo; brain fog; dizziness; Likely Cranial Nerve 8 inflammation; cognitive difficulties; Have been unable to work for three weeks; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 20Aug2021 17:00 (Lot number: EW0185) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Onset date: Childhood; "Known allergies: seasonal allergies" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Allergic rhinitis" (unspecified if ongoing), notes: Onset date: Childhood. Concomitant medication(s) included: FLUVENT taken for asthma; ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for rhinitis allergic; PROAIR HFA taken for asthma; VITAMIN D3 taken for asthma. The following information was reported: VERTIGO (non-serious) with onset 21Aug2021 08:00, outcome "not recovered", described as "Vertigo"; FEELING ABNORMAL (non-serious) with onset 21Aug2021 08:00, outcome "recovering", described as "brain fog"; DIZZINESS (non-serious) with onset 21Aug2021 08:00, outcome "recovering", described as "dizziness"; CRANIAL NERVE DISORDER (non-serious) with onset 21Aug2021 08:00, outcome "not recovered", described as "Likely Cranial Nerve 8 inflammation"; COGNITIVE DISORDER (non-serious) with onset 21Aug2021 08:00, outcome "not recovered", described as "cognitive difficulties"; IMPAIRED WORK ABILITY (non-serious) with onset 21Aug2021 08:00, outcome "not recovered", described as "Have been unable to work for three weeks"; HEADACHE (non-serious) with onset 24Aug2021, outcome "not recovered", described as "headache"; HEAD DISCOMFORT (non-serious) with onset 24Aug2021, outcome "not recovered", described as "head pressure"; NAUSEA (non-serious) with onset 24Aug2021, outcome "not recovered", described as "nausea"; VISION BLURRED (non-serious) with onset 24Aug2021, outcome "not recovered", described as "blurred vision"; NYSTAGMUS (non-serious) with onset 24Aug2021, outcome "not recovered", described as "nystagmus"; TINNITUS (non-serious) with onset 24Aug2021, outcome "not recovered", described as "tinnitus in left ear". The events "vertigo", "brain fog", "dizziness", "likely cranial nerve 8 inflammation", "cognitive difficulties", "have been unable to work for three weeks", "headache", "head pressure", "nausea", "blurred vision", "nystagmus" and "tinnitus in left ear" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vertigo, feeling abnormal, dizziness, cranial nerve disorder, cognitive disorder, impaired work ability, headache, head discomfort, nausea, vision blurred, nystagmus, tinnitus.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received any other medications within 2 weeks of vaccination included Allergy shots taken for allergy rhinitis. Vertigo starting Day after injection. On day 4 vertigo intensified, accompanied by headache, brain fog, head pressure, nausea, blurred vision, nystagmus and tinnitus in left ear. MRI negative and bloodwork negative for abnormalities. Likely Cranial Nerve 8 inflammation. Awaiting appointment with ENT/ neurologist. Vertigo headaches and tinnitus still present as of Day 23 with intermittent blurred vision and cognitive difficulties. Have been unable to work for three weeks. Adverse event treatment included Multiple medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Event Dizziness was treated with meclizine, Ativan, prednisone, Imitrex.  Follow-up attempts are completed. No further information is expected.